These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10716661)

  • 1. Recent insights into the molecular pathogenesis of Huntington disease.
    Leavitt BR; Wellington CL; Hayden MR
    Semin Neurol; 1999; 19(4):385-95. PubMed ID: 10716661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances on the pathogenesis of Huntington's disease.
    Petersén A; Mani K; Brundin P
    Exp Neurol; 1999 May; 157(1):1-18. PubMed ID: 10222105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models.
    Schilling G; Klevytska A; Tebbenkamp AT; Juenemann K; Cooper J; Gonzales V; Slunt H; Poirer M; Ross CA; Borchelt DR
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):313-20. PubMed ID: 17413322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington disease: new insights on the role of huntingtin cleavage.
    Wellington CL; Leavitt BR; Hayden MR
    J Neural Transm Suppl; 2000; (58):1-17. PubMed ID: 11128600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective degeneration in YAC mouse models of Huntington disease.
    Van Raamsdonk JM; Warby SC; Hayden MR
    Brain Res Bull; 2007 Apr; 72(2-3):124-31. PubMed ID: 17352936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
    Hannan AJ
    Acta Biochim Pol; 2004; 51(2):415-30. PubMed ID: 15218539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease.
    Gil JM; Rego AC
    Brain Res Rev; 2009 Mar; 59(2):410-31. PubMed ID: 19118572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial depletion of CREB-binding protein reduces life expectancy in a mouse model of Huntington disease.
    Klevytska AM; Tebbenkamp AT; Savonenko AV; Borchelt DR
    J Neuropathol Exp Neurol; 2010 Apr; 69(4):396-404. PubMed ID: 20448484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.
    Rué L; Bañez-Coronel M; Creus-Muncunill J; Giralt A; Alcalá-Vida R; Mentxaka G; Kagerbauer B; Zomeño-Abellán MT; Aranda Z; Venturi V; Pérez-Navarro E; Estivill X; Martí E
    J Clin Invest; 2016 Nov; 126(11):4319-4330. PubMed ID: 27721240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of mitochondria in the pathogenesis of Huntington's disease].
    Karachitos A; Gałgańska H; Kmita H
    Postepy Biochem; 2010; 56(2):174-81. PubMed ID: 20873112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compromised IGF signaling causes caspase-6 activation in Huntington disease.
    Skotte NH; Pouladi MA; Ehrnhoefer DE; Huynh K; Qiu X; Nielsen SMB; Nielsen TT; Nørremølle A; Hayden MR
    Exp Neurol; 2020 Oct; 332():113396. PubMed ID: 32622701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo proof-of-concept of removal of the huntingtin caspase cleavage motif-encoding exon 12 approach in the YAC128 mouse model of Huntington's disease.
    Casaca-Carreira J; Toonen LJA; Evers MM; Jahanshahi A; van-Roon-Mom WMC; Temel Y
    Biomed Pharmacother; 2016 Dec; 84():93-96. PubMed ID: 27639545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo.
    O'Brien R; DeGiacomo F; Holcomb J; Bonner A; Ring KL; Zhang N; Zafar K; Weiss A; Lager B; Schilling B; Gibson BW; Chen S; Kwak S; Ellerby LM
    J Biol Chem; 2015 Jul; 290(31):19287-306. PubMed ID: 26025364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington disease: new insights into the relationship between CAG expansion and disease.
    Nasir J; Goldberg YP; Hayden MR
    Hum Mol Genet; 1996; 5 Spec No():1431-5. PubMed ID: 8875248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial rescue of some features of Huntington Disease in the genetic absence of caspase-6 in YAC128 mice.
    Wong BKY; Ehrnhoefer DE; Graham RK; Martin DDO; Ladha S; Uribe V; Stanek LM; Franciosi S; Qiu X; Deng Y; Kovalik V; Zhang W; Pouladi MA; Shihabuddin LS; Hayden MR
    Neurobiol Dis; 2015 Apr; 76():24-36. PubMed ID: 25583186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspases in Huntington's disease.
    Sanchez Mejia RO; Friedlander RM
    Neuroscientist; 2001 Dec; 7(6):480-9. PubMed ID: 11765125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
    Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
    JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's disease, calcium, and mitochondria.
    Giacomello M; Hudec R; Lopreiato R
    Biofactors; 2011; 37(3):206-18. PubMed ID: 21674644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel caspase cleavage site in huntingtin that regulates mutant huntingtin clearance.
    Martin DDO; Schmidt ME; Nguyen YT; Lazic N; Hayden MR
    FASEB J; 2019 Mar; 33(3):3190-3197. PubMed ID: 30423259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease.
    Yu-Taeger L; Petrasch-Parwez E; Osmand AP; Redensek A; Metzger S; Clemens LE; Park L; Howland D; Calaminus C; Gu X; Pichler B; Yang XW; Riess O; Nguyen HP
    J Neurosci; 2012 Oct; 32(44):15426-38. PubMed ID: 23115180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.